Navigation Links
John Theurer Cancer Center Announces Positive Results from Revlimid MCL-001(EMERGE) Study Leading to FDA Approval of First Oral Therapy for Refractory Mantle-Cell Lymphoma (MCL) Patients
Date:9/26/2013

with MD Anderson Cancer Center and a number of institutions around the world. This study reported the impressive activity of the first BTK (Bruton's Tyrosine Kinase) inhibitor called PCI-32765 or ibrutinib. Ibrutinib belongs to a new category of drugs targeting the BCR (B-cell receptor) pathway, which appears very critical for B-cells and lymphoma cells' survival. Ibrutinib was very well tolerated and showed activity in almost three-fourths of the patients with very durable responses. Ibrutinib is currently under priority review by the FDA as an additional therapeutic treatment option. ("Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma" NEJM August 2013).

"These two new drugs represent great hope for patients with relapsed/refractory mantle-cell lymphoma and offer a terrific opportunity moving forward for treatments in combination or after conventional chemotherapy (as maintenance or consolidation), which will definitely improve the outcome of mantle-cell lymphoma patients," said Andre Goy, M.D., M.S.

Dr. Goy previously showed the first activity of bortezomib (proteasome inhibitor) and headed the trials which led to bortezomib approval as the first new drug ever approved by the FDA for relapsed/refractory mantle cell lymphoma.

"As one of the premier Lymphoma programs in the nation, we are committed to being at the forefront of cutting-edge research and treatment," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor and Vice President of Cancer Services, John Theurer Cancer Center and President of Regional Cancer Care Associates. "MCL-001 and the approval of lenalidomide represent a breakthrough in the treatment of mantle-cell lymphoma."

About John Theurer Cancer Center at Hackensack University Medical Center
John Theurer Cancer Center at
'/>"/>

SOURCE John Theurer Cancer Center
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Revolutionary Natural Sunscreen That Can Reverse Wrinkles, Fine Lines, Sagging Skin, Laugh Lines And Potentially Reverse Cancer Cell Formation With Anti-Aging And Anti-Cancer Forming Natural Ingredients Now Available From Rejuve MD
2. New Survey Reveals U.S. Men with Advanced Prostate Cancer Worry More about Burdening Family and Friends Than Dying
3. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
4. Laser-Proton Therapy Working Group Takes Second Look at Ways to Lower Cost of Advanced Cancer Treatment
5. APPLIED INTEGRIN SCIENCES, INC. LAUNCHES CROWDFUNDING CAMPAIGN TO RAISE FUNDS FOR ITS CANCER DRUG DEVELOPMENT PROGRAM
6. In Turkey, the Use of Targeted Therapies Will Continue to Sustain the Colorectal Cancer Drug Market
7. According to Surveyed U.S. Oncologists, Zytiga is the Patient-Share Leader in First-Line Metastatic Castrate-Resistant Prostate Cancer
8. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
9. K94 Discoveries, Inc. Announces Seed Financing To Advance Targeted Drug Conjugates To Treat Pancreatic And Other Cancers
10. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
11. Study Suggests that a Single Session of Stereotactic Body Radiation Therapy (Lung Radiosurgery) is a Promising Approach for Treating Inoperable Early-Stage Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced it ... adults suffering from the severe cold weather that has gripped ... to helping those in need; so to support these emergency ... up to $250,000, which could mean up to $500,000 in ...
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender offer ...   As a result of the waiver, the transaction ... complete the tender offer on January 24, 2014 following the currently ...
(Date:1/15/2014)... Fla. , Jan. 15, 2014  In an unprecedented effort to ... TB in ambulances and other transport vehicles, an advanced and portable ... rescue personnel for the first time. In order ... with these deadly pathogens, West Palm Beach ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
... 2010 At this year,s Annual Meeting of ... Philips Electronics (NYSE: PHG, AEX: PHI) is demonstrating ... can help simplify the clinician and patient experience. ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091127/NY17547LOGO ) ...
... Inovonics ( http://www.inovonics.com ), the industry leader in ... safety applications, today announced the release of the ... specifically to meet the unique needs of senior ... EN1240 offers a significant advancement over other alternative ...
Cached Medicine Technology:Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 2Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 3Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 4Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 2Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 3Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 4
(Date:4/22/2014)... of all lung cancers are small cell lung ... resistance to chemotherapy. However, researchers at Virginia Commonwealth ... into the mechanisms leading to this resistance that ... work primarily by mediating B-cell lymphoma 2 (Bcl-2) ... death. Depending on their function, this family of ...
(Date:4/22/2014)... The International Communication Association will hold its ... The theme of the 2014 conference will explore ... and digital society. , Featuring over 2,300 academic ... Communication scholars representing over 40 countries, the ICA ... in the world. This year,s conference features sessions ...
(Date:4/22/2014)... release is available in German . ... important intracellular signaling molecules, but their mode of action ... of cellular function and behavior, while at high concentrations ... and DNA. To analyze how redox signaling unfolds in ... microscopy technique has been developed jointly by the teams ...
(Date:4/22/2014)... (SALT LAKE CITY)A computational tool developed at the University ... with unknown gene mutations in three separate cases, U ... new study in The American Journal of Human ... Re-ranking tool), identifies undiagnosed illnesses and unknown gene mutations ... proteins that code for genes are made, in individual ...
(Date:4/22/2014)... demonstrated the first size-based form of chromatography that ... living cells. This unique physical approach to probing ... whether a cell lives or dies, remains normal ... conventional microscopy. , "We,ve developed membrane-embedded nanodot array ... probe and manipulate membrane assemblies, including signaling clusters, ...
Breaking Medicine News(10 mins):Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2Health News:Neuroimaging: Live from inside the cell 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3
... benefit from a shunt used for less common brain ... -- Some people with Alzheimer,s disease may be helped ... less common neurological condition, new research suggests. , The ... cerebrospinal fluid builds up in the ventricles, or cavities, ...
... Jefferson University have found that colonoscopy preparation drugs administered ... to those given the night before and the morning ... side effects such as abdominal pain, sleep loss and ... compared results between 116 colonoscopy patients given a split ...
... ... near some of the best hospitals and clinics in the world. , ... Monsey, NY (PRWEB) May 4, 2010 -- The new All Time ... , ,"We were physically bound by how many people we were able to hire. We literally ...
... An enchanted estate ... laidback escape, in total peace. , , ... May 1, 2010 -- What is Euterpini? , , ,Eight typical local villas, the so-called dammusi, that ... the western side of the island of Pantelleria , and named after local plants and flowers ...
... ... contract partners can now ensure on-time production, gain visibility to production milestones and ... With this cloud-based solution, team members can collaborate on production orders and track ... ...
... ... marketing and product/service innovations. , ... Michigan (PRWEB) May 3, 2010 -- David Hofer has joined Michigan-based ... will also head the recruitment of team members and development of the International Bancard ...
Cached Medicine News:Health News:Surgery for Treatable Dementia Might Also Help in Alzheimer's 2Health News:Surgery for Treatable Dementia Might Also Help in Alzheimer's 3Health News:Study finds cutting colonoscopy preparation from 2 days to 1 day just as effective 2Health News:All Time Medical Has Just Moved To Their New, State-Of-The Art Office Situated In The Heart Of The Business District Of Monsey, N.Y 2Health News:Life Science Contract Manufacturing Gains Predictable On-Time Production with TraceLink's Production Tracking Solution 2Health News:Life Science Contract Manufacturing Gains Predictable On-Time Production with TraceLink's Production Tracking Solution 3Health News:Life Science Contract Manufacturing Gains Predictable On-Time Production with TraceLink's Production Tracking Solution 4Health News:David Hofer Named President of International Bancard Corporation 2
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy....
... Sysmex CA-7000 provides speed and precision ... synonymous with Sysmex technology. With ... throughput of up to 300 samples ... multi-parameter testing. This high performance, ...
... CA-1500 enhances productivity in the laboratory with ... detection methods clotting, chromogenic and immunological ... precise test results every time. With ... and random access, the CA-1500 will provide ...
... is the lancing device that has set ... since 1983. This re-usable lancing device assists ... The auto-Lancet is constructed in the USA ... after day, year after year. It's the ...
Medicine Products: